Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries

Circulation

Volumn 93, Issue 6, 1996, Pages 1141-1147

  Riessen, Reimer ^a   Wight, Thomas N ^b   Pastore, Christopher ^a   Henley, Courtney ^a   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

arteriosclerosis; collagen; hyaluronic acid; remodeling; restenosis

Indexed keywords

HYALURONIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHERECTOMY; BALLOON CATHETER; CAROTID ARTERY OBSTRUCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

EID: 0029868877     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.6.1141     Document Type: Article

References (59)

1. Nobuyoshi M, Kimura T, Nosaka H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12:616-623.
2. Serruys PW, Luijten HE, Beat KJ, Geuskens R, De Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, and 3 months. Circulation. 1988;77:361-372.
3. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 1990;17:433-439.
4. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Morphologic observations late (>30 days) after clinically successful coronary balloon angioplasty. Circulation. 1991;83(suppl I):I-28-I-41.
5. Johnson DE, Hinohara T, Selmon MR, Braden W, Simpson JB. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol. 1990;15:419-425.
6. Garratt KN, Edwards WD, Kaufmann UP, Vlietstra RE, Holmes DR. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol. 1991;17:442-448.
7. Miller MJ, Kuntz RE, Friedrich SP, Leidig GA, Fishman RF, Schnitt SJ, Baim DS, Safian RD. Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. Am J Cardiol. 1993;71:652-658.
8. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 1994;144: 962-974.
9. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
10. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
11. Hay ED. Cell Biology of Extracellular Matrix. New York, NY: Plenum Press; 1991.
12. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay E, ed. Cell Biology of the Extracellular Matrix. New York, NY: Plenum Press; 1991:305-341.
13. Laurent TC, Fraser TC. Hyaluronan. FASEB J. 1992;6:2397-2404.
14. Rooney P, Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation. 1993;54: 1-9.
15. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol. 1986;11:219-234.
16. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6:726-733.
17. Oksala O, Salo T, Tammi R, Häkkinen L, Jalkanen M, Inki P, Larjava H. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem. 1995;43:125-135.
18. Simpson JB, Selmon MR, Robertson GC, Cipriano PR, Hayden WG, Johnson DE, Fogarty TJ. Transluminal atherectomy for occlusive peripheral vascular disease. Am J Cardiol. 1988;61:96G-101G.
19. Safian RD, Gelbfish JS, Erny RE, Schmitt SJ, Schmidt DA, Baim DS. Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation. 1990;82:69-79.
20. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle cell growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
21. Ripellino JA, Klinger MM, Margolis RU, Margolis RK. The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. J Histochem Cytochem. 1985;33: 1060-1066.
22. Waldenström A, Martinussen HJ, Gerdin B, Hällgren R. Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest. 1991;88:1622-1628.
23. Green SJ, Tarone G, Underhill CB. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J Cell Sci. 1988;89: 145-156.
24. Shekonin BV, Domogatsky SP, Muzykantov VR, Idelson GL, Rukosuev VS. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. Collagen Rel Res. 1985;5:355-368.
25. Godfrey M, Keene DR, Blank E, Hori H, Sakai LY, Sherwin LA, Hollister DW. Type II achondrogenesis-hypochondrogenesis: morphologic and immunohistopathologic studies. Am J Hum Genet. 1988;43:895-903.
26. Tsukada T, Tippens D, Gordon D, Ross R, Gown AM. HHF35, a muscle-actin-specific monoclonal antibody, I: immunocytochemical and biochemical characterization. Am J Pathol. 1987;126:51-60.
27. Gown AM, Tsukada T, Ross R. Human atherosclerosis, II: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
28. Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 1993;91:1469-1480.
29. Hall P, Devison D, Woods A, Yu C-W, Kellock D, Watkins J, Barnes D, Gillet R, Camplejohn R, Waseem N, Lane D. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285-294.
30. Gelb AB, Kamel OW, LeBrun DP, Warnke RA. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/cyclin monoclonal antibodies. Am J Pathol. 1992;141:1453-1458.
31. Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb. 1993;13:609-617.
32. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res. 1993;73:223-231.
33. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
34. Clark RAF, Henson PM. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press; 1988.
35. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol. 1994;6:717-725.
36. Ylä-Herttuala S, Sumuvuori H, Karkola K, Mötönen M, Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest. 1986;54:402-407.
37. Heickendorff L, Ledet T, Rasmussen LM. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia. 1994; 37:286-292.
38. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis. 1986;6:585-593.
39. Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis. 1994;105:51-62.
40. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993; 13:1218-1226.
41. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
42. Helin P, Lorenzen I, Garbarsch C, Mattiessen ME. Repair in arterial tissue: morphological and biochemical changes in rabbit aorta after a single dilation injury. Circ Res. 1971;29:542-554.
43. Heldin P, Laurent TC, Heldin CH. Effects of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J. 1989;258:919-922.
44. 1 stimulation of cell locomotion utilizes the hyaluronate receptor RHAMM and hyaluronan. J Cell Biol. 1993; 123:749-758.
45. Casscells W. Smooth muscle cell growth factors. Prog Growth Factor Res. 1991;3:177-206.
46. Boudreau N, Turley E, Rabinovitch M. Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol. 1991;143:235-247.
47. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 1992;117:1343-1350.
48. Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 1994;13:286-296.
49. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
50. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate synthesis is required for fibroblasts detachment and mitosis. Biochem J. 1986;239:445-450.
51. Deudon E, Berrou E, Breton M, Picard J. Growth-related production of proteoglycans and hyaluronic acid in synchronous arterial smooth muscle cells. Int J Biochem. 1992;24:465-470.
52. Orgill D, Demling RH. Current concepts and approaches to wound healing. Crit Care Med. 1988;16:899-908.
53. Reiser KM, McCormick R, Rucker RB. Enzymatic and nonenzymatic cross-linking of collagen. FASEB J. 1992;6:2439-2449.
54. Isner JM. Vascular remodeling. Circulation. 1994;89:2937-2941.
55. Mintz GS, Kovach JA, Javier SP, Ditrano CJ, Leon MB. Geometric remodeling is the predominant mechanism of late lumen loss after coronary angioplasty. Circulation. 1993;88(suppl I):I-654. Abstract.
56. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
57. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
58. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816-2821.
59. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1002.